{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:24:41Z","timestamp":1791645881123,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Beh\u00e7et\u2019s syndrome (BS) is a multi-systemic vasculitis characterized by recurrent oral ulcers, genital ulcers, ocular lesions, and other systemic manifestations. As there is no laboratory diagnostics of BS, the diagnosis is mainly clinical.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the utility of the autoantibody against tubulin-\u03b1-1c in diagnosis of BS and its clinical significance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sixty BS patients and sixty healthy controls were enrolled in this study. We assessed all patients by Beh\u00e7et disease current activity form (BDCAF), routine laboratory investigations, and immunological markers (ANA, anti-DNA, ANCA). Anti-endothelial cell antibodies (AECA) and anti-tubulin-alpha-1c antibodies were performed for all participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Regarding duration of illness, Birmingham Vasculitis Activity Score (BVAS), and BDCAF, the mean value was 4.77\u2009\u00b1\u20094.239, 19.80\u2009\u00b1\u200910.020, and 9.52\u2009\u00b1\u20095.476, respectively. On comparing laboratory investigations, there was only significant increase in anti-tubulin-alpha-1c antibody in BS patients compared to healthy controls. Regarding AECA, there was no any significant correlation except with CRP. Anti-tubulin-alpha-1c detected significant direct correlation with the presence of posterior uveitis, panuveitis, and venous thrombosis as well as BVAS, C4, and protein\/creatinine ratio. Regarding diagnostic performance of both AECA and anti-tubulin-alpha-1c, the cutoff value of AECA for diagnosis was 27.250, with sensitivity and specificity of 93.3% and 96.7%, respectively. The cutoff value of the anti-tubulin-alpha-1c for diagnosis was 22.300, with sensitivity and specificity of 100% and 96.7% respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Anti-tubulin-\u03b1-1c antibodies are of diagnostic value in BS and are indicative of activity with 100% sensitivity and 96.7% specificity.<\/jats:p><jats:p><jats:table-wrap><jats:table><jats:tbody><jats:tr><jats:td align=\"left\" colspan=\"2\"><jats:bold>Key Points<\/jats:bold>\u2022<jats:italic>There is lack of specific laboratory, radiological, or histological diagnostics for Behcet syndrome.<\/jats:italic>\u2022<jats:italic>We aimed to evaluate the significance of tubulin-\u03b1-1c autoantibody in diagnosis of Behcet syndrome.<\/jats:italic>\u2022<jats:italic>There is elevation of tubulin-\u03b1-1c autoantibody with sensitivity and specificity of 100% and 96.7%, respectively.<\/jats:italic><\/jats:td><\/jats:tr><\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p><\/jats:sec>","DOI":"10.1007\/s10067-021-06025-7","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T01:02:25Z","timestamp":1644195745000},"page":"1759-1767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-tubulin-alpha-1c antibody as a marker of value in Beh\u00e7et syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Mariam Maged","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama M.","family":"Abdel Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"issue":"Suppl. 102","key":"6025_CR1","first-page":"S10","volume":"34","author":"G Hatemi","year":"2016","unstructured":"Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2016) One year in review 2016: Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol 34(Suppl. 102):S10-22","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 108","key":"6025_CR2","first-page":"S3","volume":"35","author":"G Hatemi","year":"2017","unstructured":"Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2017) One year in review 2017: Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol 35(Suppl. 108):S3-15","journal-title":"Clin Exp Rheumatol"},{"key":"6025_CR3","doi-asserted-by":"publisher","unstructured":"Colburn NT (2012) Review of rheumatology. Springer\u2013Verlag London Limited. 417\u2013430. https:\/\/doi.org\/10.1007\/978-1-84882-093-75","DOI":"10.1007\/978-1-84882-093-75"},{"key":"6025_CR4","doi-asserted-by":"crossref","unstructured":"Gheita TA, El-Latif EA, El-Gazzar II, Samy N, Hammam N, A Abdel Noor R. et al (2019) Beh\u00e7et\u2019s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature [published correction appears in Clin Rheumatol. 38(9):2565\u20132575","DOI":"10.1007\/s10067-019-04570-w"},{"key":"6025_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Beh\u00e7et\u2019s disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"6025_CR6","first-page":"59","volume":"10","author":"Y Mizushima","year":"1988","unstructured":"Mizushima Y (1988) Recent research into Beh\u00e7et\u2019s disease in Japan. Int J Tissue React 10:59\u201365","journal-title":"Int J Tissue React"},{"key":"6025_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/1756-185X.12520","volume":"18","author":"F Davatchi","year":"2015","unstructured":"Davatchi F, SadeghiAbdollahi B, Chams-Davatchi C, Shahram F, Shams H, Nadji A et al (2015) The saga of diagnostic\/classification criteria in Behcet\u2019s disease. Int J Rheum Dis 18:594\u2013605","journal-title":"Int J Rheum Dis"},{"key":"6025_CR8","doi-asserted-by":"publisher","unstructured":"Davatchi F, Assaad-Khalil TS, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, et al. The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol: JEADV. 28. https:\/\/doi.org\/10.1111\/jdv.12107.2013","DOI":"10.1111\/jdv.12107.2013"},{"key":"6025_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/rheumatology\/keq331","volume":"50","author":"M Piga","year":"2011","unstructured":"Piga M, Mathieu A (2011) Genetic susceptibility to Behcet\u2019s disease: role of genes belonging to the MHC region. Rheumatology 50:299\u2013310","journal-title":"Rheumatology"},{"key":"6025_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/BOR.0000000000000003","volume":"26","author":"A Gul","year":"2014","unstructured":"Gul A (2014) Genetics of Behcet\u2019s disease: lessons learned from genome wide association studies. Curr Opin Rheumatol 26:56\u201363","journal-title":"Curr Opin Rheumatol"},{"key":"6025_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","volume":"37","author":"JC Chambers","year":"2001","unstructured":"Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Beh\u00e7et\u2019s syndrome. J Am Coll Cardiol 37:517\u2013520","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"6025_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/cei.12655","volume":"181","author":"N Ambrose","year":"2015","unstructured":"Ambrose N, Khan E, Ravindran R, Lightstone L, Abraham S, Botto M et al (2015) The exaggerated inflammatory response in Behcet\u2019s syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-gamma\/CXCL10 IP-10pathway. Clin Exp Immunol 181(3):427\u2013433","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"6025_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/BOR.0000000000000125","volume":"27","author":"JH Cheon","year":"2015","unstructured":"Cheon JH, Kim WH (2015) An update on the diagnosis, treatment, and prognosis of intestinal Beh\u00e7et\u2019s disease. Curr Opin Rheumatol 27(1):24\u201331","journal-title":"Curr Opin Rheumatol"},{"key":"6025_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/096120339700600608","volume":"6","author":"M Navarro","year":"1997","unstructured":"Navarro M, Cervera R, Font J, Reverter JC, Monteagudo J, Escolar G et al (1997) Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 6:521\u2013526","journal-title":"Lupus"},{"key":"6025_CR15","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/1529-0131(200107)44:7<1484::AID-ART269>3.0.CO;2-Q","volume":"44","author":"S Praprotnik","year":"2001","unstructured":"Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y (2001) Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 44:1484\u20131494","journal-title":"Arthritis Rheum"},{"key":"6025_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/clin.1993.1059","volume":"67","author":"AO Aydintug","year":"1993","unstructured":"Aydintug AO, Tokgoz G, D\u00c7ruz DP, Gurler A, Cervera R, Duzgun N et al (1993) Antibodies to endothelial cells in patients with Beh\u00e7et\u2019s disease. Clin Immunol Immunopathol. 67:157\u2013162","journal-title":"Clin Immunol Immunopathol."},{"key":"6025_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/ard.53.4.265","volume":"53","author":"R Cervera","year":"1994","unstructured":"Cervera R, Navarro M, Lopez-Soto A, Cid MC, Font J, Esparza J et al (1994) Antibodies to endothelial cells in Beh\u00e7et\u2019s disease: cell-binding heterogeneity and association with clinical activity. Ann Rheum Dis 53:265\u2013267","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6025_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9","volume":"32","author":"F Mor","year":"2002","unstructured":"Mor F, Weinberger A, Cohen IR (2002) Identification of alpha-tropomyosin as a target self-antigen in Behcet\u2019s syndrome. Eur J Immunol 32(2):356\u2013365","journal-title":"Eur J Immunol"},{"issue":"7","key":"6025_CR19","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/art.11074","volume":"48","author":"KH Lee","year":"2003","unstructured":"Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH et al (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet\u2019s disease. Arthritis Rheum 48(7):2025\u20132035","journal-title":"Arthritis Rheum"},{"issue":"6","key":"6025_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1348-0421.2010.00215.x","volume":"54","author":"S Ooka","year":"2010","unstructured":"Ooka S, Nakano H, Matsuda T, Okamoto K, Suematsu N, Kurokawa MS et al (2010) Proteomic surveillance of autoantigens in patients with Behcet\u2019s disease by a proteomic approach. Microbiol Immunol 54(6):354\u2013361","journal-title":"Microbiol Immunol"},{"issue":"11","key":"6025_CR21","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.4049\/jimmunol.175.11.7678","volume":"175","author":"M Keller","year":"2005","unstructured":"Keller M, Spanou Z, Schaerli P, Britschgi M, Yawalkar N, Seitz M et al (2005) T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol 175(11):7678\u20137686","journal-title":"J Immunol"},{"issue":"4 Suppl 84","key":"6025_CR22","first-page":"S9","volume":"32","author":"T Yoshioka","year":"2014","unstructured":"Yoshioka T, Kurokawa MS, Sato T, Nagai K, Iizuka N, Arito M et al (2014) Protein profiles of peripheral blood mononuclear cells as a candidate biomarker for Behcet\u2019s disease. Clin Exp Rheumatol 32(4 Suppl 84):S9-19","journal-title":"Clin Exp Rheumatol"},{"issue":"4Suppl 60","key":"6025_CR23","first-page":"S31","volume":"28","author":"SB Cho","year":"2010","unstructured":"Cho SB, Lee JH, Ahn KJ, Cho S, Park YB, Lee SK et al (2010) Identification of streptococcal proteins reacting with sera from Behcet\u2019s disease and rheumatic disorders. Clin Exp Rheumatol 28(4Suppl 60):S31-38","journal-title":"Clin Exp Rheumatol"},{"key":"6025_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1083\/jcb.201406055","volume":"206","author":"C Janke","year":"2014","unstructured":"Janke C (2014) The tubulin code: molecular components, readout mechanisms, and functions. J Cell Biol 206:461\u2013472","journal-title":"J Cell Biol"},{"issue":"2","key":"6025_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg L, Hallstr\u00f6m BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13(2):397\u2013406","journal-title":"Mol Cell Proteomics"},{"key":"6025_CR26","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.4049\/jimmunol.180.7.4487","volume":"180","author":"TA Goers","year":"2008","unstructured":"Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, De MT (2008) novo production of K-\u03b11 tubulin specific antibodies: role in chronic lung allograft rejection. J Immunol 180:4487\u20134494","journal-title":"J Immunol"},{"issue":"8","key":"6025_CR27","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","volume":"12","author":"RR Hachema","year":"2012","unstructured":"Hachema RR, Tiriveedhib V, Pattersonc G, Aloush A, Trulock EP, Mohanakumar T (2012) Antibodies to K-\u03b11tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant 12(8):2164\u20132171","journal-title":"Am J Transplant"},{"issue":"Suppl 50","key":"6025_CR28","first-page":"S1","volume":"26","author":"International team for the revision of international criteria for Beh\u00e7et\u2019s disease","year":"2008","unstructured":"International team for the revision of international criteria for Beh\u00e7et\u2019s disease (2008) Clinical manifestations of for Beh\u00e7et\u2019s disease The ITR-ICBD report. Clin Exp Rheumatol 26(Suppl 50):S1\u2013S18","journal-title":"Clin Exp Rheumatol"},{"key":"6025_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2230.2006.02284.x","volume":"32","author":"M Ozdemir","year":"2007","unstructured":"Ozdemir M, Balevi S, Deniz F, Mevlito\u011flu I (2007) Pathergy reaction in different body areas in Beh\u00e7et\u2019s disease. Clin Exp Dermatol 32:85\u201387","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"6025_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1590\/S0482-50042009000100003","volume":"49","author":"FD Neves","year":"2009","unstructured":"Neves FD, Caldas CM, de Medeiros DM, de Moraes JB, Gon\u00e7alves CR (2009) Cross-cultural adaptation of simplified version (s) of Beh\u00e7et\u2019s Disease Current Activity Form (BDCAF) and comparison between two different instruments with Brazilian versions for evaluating Beh\u00e7et\u2019s disease activity: BR-BDCAF and BR-BDCAF (s). Rev Bras Reumatol 49(1):20\u201331","journal-title":"Rev Bras Reumatol"},{"key":"6025_CR31","first-page":"671","volume":"87","author":"RA Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671\u2013678","journal-title":"QJM"},{"issue":"10","key":"6025_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"M Pineton De Chambrun","year":"2012","unstructured":"Pineton De Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D (2012) New insights into the pathogenesis of Behcet\u2019s disease. Autoimmun Rev 11(10):687\u2013698","journal-title":"Autoimmun Rev"},{"issue":"6","key":"6025_CR33","doi-asserted-by":"publisher","first-page":"e0199047","DOI":"10.1371\/journal.pone.0199047","volume":"13","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Zhao X, Chen Y, Li Y, Jia R, Zhu L et al (2018) Circulating immune complexome analysis identified anti-tubulin-\u03b1-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet\u2019s disease. PLoS ONE. 13(6):e0199047","journal-title":"PLoS ONE."},{"issue":"4 Suppl. 30","key":"6025_CR34","first-page":"S27","volume":"21","author":"A Dinc","year":"2003","unstructured":"Dinc A, Takafuta T, Jiang D, Melikoglu M, Saruhan-Direskeneli G, Shapiro SS (2003) Anti-endothelial cell antibodies in Behcet\u2019s disease. Clin Exp Rheumatol 21(4 Suppl. 30):S27\u2013S30","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"6025_CR35","first-page":"910","volume":"44","author":"WJ Zheng","year":"2005","unstructured":"Zheng WJ, Zhao Y, Tang FL, Dong YY (2005) A study of antiendothelial cell antibodies in Behcet\u2019s disease. Zhonghua Nei Ke Za Zhi 44(12):910\u2013913","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"6025_CR36","first-page":"231","volume":"132C","author":"S Avrameas","year":"1981","unstructured":"Avrameas S, Guilbert B, Dighiero G (1981) Natural antibodies against tubulin, actin myoglobin, thyroglobulin, fetuin, albumin and transferrin are present in normal human sera and monoclonal immunoglobulins from multiple myeloma and Waldenstr\u00f6m\u2019s macroglobulinemia may express similar antibody specificities. Ann Immunol (Paris) 132C:231\u2013236","journal-title":"Ann Immunol (Paris)"},{"key":"6025_CR37","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.4049\/jimmunol.128.6.2788","volume":"128","author":"G Dighiero","year":"1982","unstructured":"Dighiero G, Guilbert B, Avrameas S (1982) Naturally occurring antibodies against nine common antigens in humans\u2019 sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies. J Immunol 128:2788\u20132792","journal-title":"J Immunol"},{"key":"6025_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0022-1759(84)90462-9","volume":"67","author":"P Kurki","year":"1984","unstructured":"Kurki P, Virtanen I (1984) The detection of human antibodies against cytoskeletal components. J Immunol Methods 67:209\u2013223","journal-title":"J Immunol Methods"},{"key":"6025_CR39","first-page":"383","volume":"59","author":"J Newcombe","year":"1985","unstructured":"Newcombe J, Gahan S, Cuzner ML (1985) Serum antibodies against central nervous system proteins in human demyelinating disease. Clin Exp Immunol 59:383\u2013390","journal-title":"Clin Exp Immunol"},{"key":"6025_CR40","unstructured":"Rousset B, Bernier-Valentin F, Poncet C, Orgiazzi J, Madec AM, Monier JC (1983) Mornex R Anti-tubulin antibodies in autoimmune thyroid disorders. Clin Exp Immuno. l52: 325\u2013332"},{"issue":"1","key":"6025_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2133.2006.07536.x","volume":"156","author":"O Shaker","year":"2007","unstructured":"Shaker O, Ay El-Deen MA, El Hadidi H, Grace BD, El Sherif H, Abdel Halim A et al (2007) The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet disease. Br J Dermatol 156(1):32\u201337","journal-title":"Br J Dermatol"},{"key":"6025_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","volume":"70","author":"I Balta","year":"2014","unstructured":"Balta I, Balta S, Koryurek OM, Demirkol S, Mikhailidis DP, Celik T et al (2014) Serum endocan levels as a marker of disease activity in patients with Behcet\u2019s disease. J Am Acad Dermatol 70:291\u2013296","journal-title":"J Am Acad Dermatol"},{"key":"6025_CR43","first-page":"2058","volume":"21","author":"T Yoshio","year":"1994","unstructured":"Yoshio T, Masuyama J, Sumiya M, Minota S, Kano S (1994) Anti-endothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 21:2058\u20132063","journal-title":"J Rheumatol"},{"issue":"77","key":"6025_CR44","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.4049\/jimmunol.180.7.4487","volume":"180","author":"TA Goers","year":"2008","unstructured":"Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, Mohanakumar T et al (2008) De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 180(77):4487\u20134494","journal-title":"J Immunol"},{"key":"6025_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-386033-0.00001-3","volume":"292","author":"CH Aylett","year":"2011","unstructured":"Aylett CH, Lowe J, Amos LA (2011) New insights into the mechanisms of cytomotive actin and tubulin filaments. Int Rev Cell Mol Biol 292:1\u201371","journal-title":"Int Rev Cell Mol Biol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-06025-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T03:03:50Z","timestamp":1674702230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-06025-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6025"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-06025-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}